General Information of Drug (ID: DMD3CUJ)

Drug Name
T-5224 Drug Info
Synonyms AKOS003047196; T5224
Cross-matching ID
PubChem CID
23626877
ChEBI ID
CHEMBL3222137
TTD Drug ID
D02LCL

Consensus Signature of Drug Pharmacogenomic Perturbation (DPP)

Term Name NES FDR q-val Tag % Leading Edge Genes
Glycine, serine and threonine metabolism 2.11 0.00e+0 31/40 (77.5%) DLD;GATM;CBS;...
Drug metabolism 2.06 0.00e+0 78/151 (51.66%) ADH1B;ADH5;NME4;...
Pentose and glucuronate interconversions 1.83 6.30e-3 17/34 (50%) AKR1B10;AKR1B1;DCXR;...
Systemic lupus erythematosus 1.82 4.72e-3 45/135 (33.33%) C7;CD40;C1S;...
Cell cycle 1.80 3.78e-3 110/124 (88.71%) CDKN2A;CDC20;SFN;...
Proximal tubule bicarbonate reclamation 1.78 1.42e-2 21/23 (91.3%) AQP1;CA2;FXYD2;...
RNA polymerase 1.77 1.48e-2 23/31 (74.19%) POLR2I;POLR2L;POLR3K;...
DNA replication 1.76 2.01e-2 34/36 (94.44%) RPA3;RFC4;MCM4;...
Complement and coagulation cascades 1.76 1.78e-2 76/85 (89.41%) CLU;C7;CD59;...
Metabolism of xenobiotics by cytochrome P450 1.73 2.08e-2 49/77 (63.64%) ADH1B;ADH5;CYP1B1;...
Retinol metabolism 1.70 3.35e-2 41/68 (60.29%) ADH1B;ADH5;UGT2B28;...
Intestinal immune network for IgA production 1.69 3.23e-2 38/48 (79.17%) CXCL12;CD40;TNFRSF17;...
Non-homologous end-joining 1.68 3.63e-2 11/13 (84.62%) XRCC5;DCLRE1C;DNTT;...
Pyrimidine metabolism 1.68 3.37e-2 40/56 (71.43%) DCK;NME4;UPP1;...
Homologous recombination 1.65 4.85e-2 35/41 (85.37%) RPA3;BARD1;RAD54B;...
Rheumatoid arthritis 1.65 4.60e-2 78/93 (83.87%) CXCL12;CXCL2;TLR4;...
×

Pharmacogenomic Perturbation Across Diseases and Tissues

Breast
Breast adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
MCF7 CVCL_0031 Homo sapiens 0.01uM - 10uM 24H
MDA-MB-231 CVCL_0062 Homo sapiens 0.01uM - 10uM 24H
Breast epithelium
Normal
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
MCF-10A CVCL_0598 Homo sapiens 0.01uM - 10uM 24H
Cervix
Cervical adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HeLa CVCL_0030 Homo sapiens 0.01uM - 10uM 24H
Colon
Colorectal adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HT-29 CVCL_0320 Homo sapiens 0.01uM - 10uM 24H
Kidney
Normal (Immortalized)
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HA1E CVCL_0284 Homo sapiens 0.01uM - 10uM 24H
Normal (Transformed)
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HEK293 CVCL_0045 Homo sapiens 0.01uM - 10uM 24H
Lung
Lung adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A549 CVCL_0023 Homo sapiens 0.01uM - 10uM 24H
Pancreas
Pancreatic carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
YAPC CVCL_1791 Homo sapiens 0.01uM - 10uM 24H
Peripheral blood
Acute monocytic leukemia
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
THP-1 CVCL_0006 Homo sapiens 0.01uM - 10uM 24H
T-cell acute lymphoblastic leukemia
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
Jurkat CVCL_0367 Homo sapiens 0.01uM - 10uM 24H
Prostate
Prostate carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
PC-3 CVCL_0035 Homo sapiens 0.01uM - 10uM 24H
Skin
Melanoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A-375 CVCL_0132 Homo sapiens 0.04uM - 10uM 24H
Umbilical vein
Normal
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HUVEC-C CVCL_2959 Homo sapiens 0.01uM - 10uM 24H